|
| |
Biomegnetics Diagnostics Corporation (OTC: BMGP) through its wholly owned subsidiary,
Bio-Spectrum Technologies, Inc. holds revolutionary patented technologies that can potentially re-vitalize
the diagnostics industry. The first product is the patented High Throughput Screening-Magnetic Testing Platform (HTS-MTP) diagnostic system.
 We have designed our system to offer the medical industry a unique method that provides confirmatory
and viral load diagnostics at the same cost of screening assays. The HTS-MTP will detect any virus or bacteria and count the viral load
in a matter of minutes and has the capabilities of screening several hundred percent more assays / hour at a fraction of the cost of
current technologies.
|
|
|
| |
The HTS-MTP is designed to detect the virus and count the viral load in a matter of minutes. No other screening, or confirmatory test,
has the ability to measure viral load, a critical measurement in developing drugs and vaccines.
HTS-MTP also has the capability to screen several hundred percent more assays, per hour, at a fraction of the cost of current
technology. The Company's product/process will raise the benchmark for the industry.
|
|
|
